RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
0.9600
+0.0591 (6.56%)
At close: Jan 29, 2026, 4:00 PM EST
0.9700
+0.0100 (1.04%)
After-hours: Jan 29, 2026, 4:21 PM EST
RenovoRx Revenue
RenovoRx had revenue of $266.00K in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $928.00K. In the year 2024, RenovoRx had annual revenue of $43.00K.
Revenue (ttm)
$928.00K
Revenue Growth
n/a
P/S Ratio
31.50
Revenue / Employee
$92,800
Employees
10
Market Cap
35.10M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 43.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cue Biopharma | 7.10M |
| Dyadic International | 3.34M |
| Outlook Therapeutics | 1.41M |
| Pluri | 1.33M |
| Hyperion DeFi | 345.32K |
RNXT News
- 1 day ago - RenovoRx Announces Acceptance of Clinical Data Abstract at 2026 Society of Interventional Oncology Annual Scientific Meeting - GlobeNewsWire
- 9 days ago - RenovoRx Expands RenovoCath® Commercial Adoption to Nine Active Cancer Centers Including City of Hope Cancer Center and Moffitt Cancer Center - GlobeNewsWire
- 15 days ago - RenovoRx to Participate in AlphaNorth Capital Event, January 16-18, 2026 - GlobeNewsWire
- 21 days ago - RenovoRx To Announce Promising New Clinical Data Using its TAMP™ Therapy Platform in an Abstract to be Presented at ASCO GI 2026 - GlobeNewsWire
- 7 weeks ago - RenovoRx Announces Acceptance of Clinical Data Abstract at the ASCO Gastrointestinal Cancers Symposium 2026 - GlobeNewsWire
- 7 weeks ago - RenovoRx, Inc. (RNXT) Presents at IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 Transcript - Seeking Alpha
- 2 months ago - RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9th - GlobeNewsWire
- 2 months ago - RenovoRx CEO Shaun Bagai to Present at the Alliance Global Partners Emerging AgBiotech/Bio-Solutions Virtual Showcase on November 20th - GlobeNewsWire